Stay updated on Personalized ctDNA MRD Testing in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Personalized ctDNA MRD Testing in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Personalized ctDNA MRD Testing in Solid Tumors Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the context of medical and healthcare-related publications and documentation.
    Difference
    0.3%
    Check dated 2024-06-06T14:45:10.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The status of the study has changed from 'Enrolling by invitation 2023 19 6' to 'Terminated Sentinel MRD test offers no additional or increased benefits to patients compared to current marketed alternatives 2024 22 7'. This indicates that the study has been terminated because the Sentinel MRD test was found to offer no additional benefits over existing alternatives.
    Difference
    4%
    Check dated 2024-05-22T21:21:19.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:28:32.000Z thumbnail image

Stay in the know with updates to Personalized ctDNA MRD Testing in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Personalized ctDNA MRD Testing in Solid Tumors Clinical Trial page.